Following DTCC's announcement that it will explore asset tokenization on the Stellar network, Stellar's native token, XLM, has seen a significant surge. Reports indicate that XLM has risen nearly 50% in the past two days, with a cumulative increase of approximately 96% over the past seven days.
Involving stocks, ETFs and US Treasury bonds
This exploration has attracted attention because the DTCC is a crucial infrastructure institution in global financial markets. The report mentions that the plan may encompass tokenized versions of Russell 1000 constituent stocks, major ETFs, and US Treasury bonds.
If the relevant arrangements enter the pilot phase, the Stellar network is expected to support more real-world asset on-chain scenarios, which will also strengthen market expectations for its institutional application prospects.
Institutional interest drives market reaction
For the crypto market, the participation of traditional financial infrastructure institutions in on-chain settlement and asset issuance is often seen as a stronger signal of adoption. Following this announcement, XLM's price reacted significantly faster than most mainstream tokens.
The market's focus is not only on the short-term gains, but also on whether Stellar can use this to obtain a clearer path for institutional cooperation, and whether its tokenization business can form a sustainable narrative.
The focus will then shift to pilot programs and approvals.
Currently, publicly available information is still limited. What deserves more attention going forward is whether a formal pilot program will be launched, whether the relevant products can obtain regulatory approval, and how asset issuance, custody, and settlement will be implemented on the Stellar network.
- Whether to disclose pilot projects and partners
- Are there any specific tokenization product plans?
- Is the progress of regulatory approvals clear?
If more implementation details are disclosed later, expectations for the institutionalization of the Stellar ecosystem may continue to rise; if progress remains at the research stage, market enthusiasm may also decline.
